This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

High Lantern Group Adds Drew Holzapfel To New York Office

NEW YORK, April 1, 2013 /PRNewswire/ -- Drew Holzapfel, a senior healthcare executive with more than 15 years of experience in corporate public affairs, sales and marketing across the pharmaceutical and biotechnology industries, has joined High Lantern Group as a Managing Director in the New York office. Holzapfel is an innovator of progressive programs and strategic partnerships to shape healthcare public policy to better meet the needs of patients and their caregivers both in the United States and internationally.

"Drew's skills in strategic communications and coalition building, his unique knowledge of U.S. and international healthcare systems and policy, and his expertise in the pharmaceutical and biotechnology industries will greatly enhance High Lantern Group's work in the areas of health and aging," said Michael W. Hodin, Managing Partner. "Drew will strengthen our existing service offerings and add a new level of insights and strategic thinking for our clients. We are thrilled to add him to our growing team."

Holzapfel joins High Lantern Group from Pfizer, where he most recently served as Director of Global Commercial Development for the company's Alzheimer's program. In this role, he led numerous efforts to advance Alzheimer's and aging issues through development of commercial strategy, advocacy and partnerships with international organizations, nongovernmental organizations, nonprofits and other key stakeholders. Prior to joining Pfizer, Holzapfel managed an external affairs team for a medical device manufacturer, helping steer the company through an initial public offering and the launch of its first product. A former Special Assistant to the Secretary of the U.S. Department of Health and Human Services in the Clinton Administration, he began his career as a political appointee working on communications for a Presidential initiative in the White House.

"High Lantern Group has built a unique niche within the consultancy business, offering great value to clients in the areas of strategic positioning and thought leadership," said Holzapfel. "I am excited to become part of this trailblazing group of professionals and follow my passion for shaping business strategies, institutions and policies to better serve global healthcare needs."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 -2.90%
FB $116.73 7.20%
GOOG $691.02 -2.10%
TSLA $247.54 -1.60%
YHOO $36.59 -0.97%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs